The Globe and Mail reports in its Saturday, Jan. 13, edition that CanniMed Therapeutics is suing a former and a current director, its largest investors, Aurora Cannabis and Canaccord Genuity Group for allegedly misusing its confidential information and conspiring to engineer Aurora's hostile takeover of CanniMed. The Globe's Christina Pellegrini writes that the lawsuit was filed in an Ontario court, but has not yet been served. The filing's allegations echo claims made by CanniMed last month at a hearing contesting Aurora's unsolicited takeover offer. CanniMed claims these people and their companies misused its confidential information and that some breached their fiduciary duty to CanniMed, according to its Statement of Claim. CanniMed is seeking damages of $725-million. CanniMed says the defendants' actions have put a ceiling on its stock and prevented it from pursuing other deals. Aurora's Cam Battley calls the lawsuit "frivolous." He says, "CanniMed had an army of lawyers trying to prove their case to the regulators and they failed," referring to last month's joint hearing over Aurora's hostile bid. "And now they're trying to achieve by lawsuit what they weren't able to achieve with the regulators."